The Spectrum of Portal Vein Thrombosis in Liver Transplantation (original) (raw)

Portal vein thrombosis, once a contraindication for orthotopic liver transplantation (OLTX), can now be managed safely with advanced surgical techniques. A series of 34 patients at the University of Pittsburgh demonstrated a 67.6% survival rate post-transplant, with higher survival correlating with techniques such as phlebothrombectomy and individualized surgical approaches based on thrombosis severity. Key findings highlight that nearly all patients with portal system thrombosis can successfully undergo transplantation, thus expanding the criteria for eligible transplant candidates.